Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation. [electronic resource]
- Bone marrow transplantation Oct 2001
- 709-11 p. digital
Publication Type: Case Reports; Journal Article; Review
0268-3369
10.1038/sj.bmt.1703211 doi
Adult Bone Marrow Transplantation--adverse effects Clarithromycin--therapeutic use Combined Modality Therapy Cyclosporine--adverse effects Debridement Drug Therapy, Combination--therapeutic use Female Graft vs Host Disease--drug therapy Humans Immunocompromised Host Immunosuppressive Agents--adverse effects Methotrexate--adverse effects Minocycline--therapeutic use Mycobacterium Infections, Nontuberculous--drug therapy Mycobacterium fortuitum--isolation & purification Precursor Cell Lymphoblastic Leukemia-Lymphoma--immunology Prednisolone--adverse effects Remission Induction Skin Ulcer--drug therapy Tacrolimus--adverse effects Transplantation Conditioning--adverse effects Transplantation, Homologous